Medicus Sciences Acquisition Corp. Unit
MSACU
MSACU was delisted on the 6th of April, 2021.
1 hedge funds and large institutions have $2.86M invested in Medicus Sciences Acquisition Corp. Unit in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 39 closing their positions.
96% less capital invested
Capital invested by funds: $80.5M → $2.86M (-$77.7M)
98% less funds holding
Funds holding: 40 → 1 (-39)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 39
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.78M |
| 2 |
HM
HealthCor Management
New York
|
-$7.78M |
| 3 |
TP
Third Point
New York
|
-$7.78M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$5.12M |
| 5 |
KC
Kepos Capital
New York
|
-$4.68M |
MSACU Hedge Fund Activity: Q2 2021 in Review
1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Unit (MSACU) for Q2 2021, worth a combined $2.86M — down 96% from $80.5M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of MSACU and 0 opened new positions — a net loss of 39 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.78M sold.
- 1 institutional investor held Medicus Sciences Acquisition Corp. Unit (MSACU) as of Q2 2021, down from 40 in Q1 2021.
- Funds reported $2.86M of Medicus Sciences Acquisition Corp. Unit stock for Q2 2021, down 96% quarter-over-quarter.
- 0 funds opened new Medicus Sciences Acquisition Corp. Unit positions in Q2 2021 and 39 closed out, a net change of -39 holders.
- The largest Medicus Sciences Acquisition Corp. Unit seller in Q2 2021 was Adage Capital Partners, an estimated $7.78M sold.
Based on aggregated 13F filings for Q2 2021.